Skip to main content
Erschienen in: Abdominal Radiology 2/2017

24.09.2016

Diagnostic performance of 18-F-FDG-PET–CT in adrenal lesions using histopathology as reference standard

verfasst von: Emre Altinmakas, Brian P. Hobbs, Hui Ye, Elizabeth G. Grubbs, Nancy D. Perrier, Victor G. Prieto, Jeffrey E. Lee, Chaan S. Ng

Erschienen in: Abdominal Radiology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the diagnostic performance of PET–CT in differentiating benign and malignant adrenal lesions when evaluating PET parameters individually as well as in combination with CT parameters, using histopathology as the reference standard.

Methods

18F-FDG-PET–CT scans of patients undertaken within 6 months prior to pathologic evaluation of their adrenal lesion(s) were evaluated. PET assessments consisted individually of maximum standardized uptake value of the adrenal lesion (A-SUVmax) and its (“normalized”) ratio to the liver (R-SUVmax). The diagnostic performances of these two PET parameters were also assessed when combined with the Hounsfield density from the non-contrast CT component of the PET–CT (A-HU). Diagnostic performance was assessed by area under the curve (AUC) of the receiver operating characteristics. Multiple logistic regression analysis was used to evaluate the individual and combined parameters.

Results

The study cohort consisted of 61 adrenal lesions (59 patients). Malignant lesions (n = 52) had significantly higher median PET and CT parameters than benign lesions: A-SUVmax (11.4 vs. 6.1), R-SUVmax (3.3 vs. 1.7), and A-HU (37 vs. 24) [all p < 0.023]. AUC for the PET parameters individually was almost identical: 0.75 for A-SUVmax and 0.74 for R-SUVmax. On univariate analysis, thresholds of A-SUVmax >3.47 and R-SUVmax >0.83 yielded maximum accuracy (both 87%). The combination of these PET parameters individually with A-HU improved both AUC and accuracy (0.81% and 93%, respectively).

Conclusions

The individual PET parameters A-SUVmax and R-SUVmax have similar diagnostic performance for differentiating malignant and benign adrenal lesions; their performance and accuracy improve when combined with the CT component (A-HU).
Literatur
1.
2.
Zurück zum Zitat Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 3(1):74–85CrossRefPubMed Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 3(1):74–85CrossRefPubMed
3.
Zurück zum Zitat Chong S, Lee KS, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls 1. Radiographics 26(6):1811–1824CrossRefPubMed Chong S, Lee KS, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls 1. Radiographics 26(6):1811–1824CrossRefPubMed
4.
Zurück zum Zitat Kunikowska J, Matyskiel R, Toutounchi S, et al. (2014) What parameters from 18F-FDG PET-CT are useful in evaluation of adrenal lesions? Eur J Nucl Med Mol Imaging 41(12):2273–2280CrossRefPubMedPubMedCentral Kunikowska J, Matyskiel R, Toutounchi S, et al. (2014) What parameters from 18F-FDG PET-CT are useful in evaluation of adrenal lesions? Eur J Nucl Med Mol Imaging 41(12):2273–2280CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Watanabe H, Kanematsu M, Goshima S, et al. (2013) Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET-CT. Ann Nucl Med 27(7):648–653CrossRefPubMed Watanabe H, Kanematsu M, Goshima S, et al. (2013) Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET-CT. Ann Nucl Med 27(7):648–653CrossRefPubMed
6.
Zurück zum Zitat Perri M, Erba P, Volterrani D, et al. (2011) Adrenal masses in patients with cancer: PET-CT characterization with combined CT histogram and standardized uptake value PET analysis. Am J Roentgenol 197(1):209–216CrossRef Perri M, Erba P, Volterrani D, et al. (2011) Adrenal masses in patients with cancer: PET-CT characterization with combined CT histogram and standardized uptake value PET analysis. Am J Roentgenol 197(1):209–216CrossRef
7.
Zurück zum Zitat Cho AR, Lim I, Choe DH, et al. (2011) Evaluation of adrenal masses in lung cancer patients using 18F-FDG PET-CT. Nucl Med Mol Imaging 45(1):52–58CrossRefPubMed Cho AR, Lim I, Choe DH, et al. (2011) Evaluation of adrenal masses in lung cancer patients using 18F-FDG PET-CT. Nucl Med Mol Imaging 45(1):52–58CrossRefPubMed
8.
Zurück zum Zitat Gratz S, Kemke B, Kaiser W, et al. (2010) Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging. J Int Med Res 38(2):633–644CrossRefPubMed Gratz S, Kemke B, Kaiser W, et al. (2010) Incidental non-secreting adrenal masses in cancer patients: intra-individual comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging. J Int Med Res 38(2):633–644CrossRefPubMed
9.
Zurück zum Zitat Ansquer C, Scigliano S, Mirallié E, et al. (2010) 18F-FDG PET-CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging 37(9):1669–1678CrossRefPubMed Ansquer C, Scigliano S, Mirallié E, et al. (2010) 18F-FDG PET-CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging 37(9):1669–1678CrossRefPubMed
10.
Zurück zum Zitat Okada M, Shimono T, Komeya Y, et al. (2009) Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG–PET–CT) in differentiating between benign and malignant lesions. Ann Nucl Med 23(4):349–354CrossRefPubMed Okada M, Shimono T, Komeya Y, et al. (2009) Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG–PET–CT) in differentiating between benign and malignant lesions. Ann Nucl Med 23(4):349–354CrossRefPubMed
11.
Zurück zum Zitat Groussin L, Bonardel G, Silvéra S, et al. (2009) 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94(5):1713–1722CrossRefPubMed Groussin L, Bonardel G, Silvéra S, et al. (2009) 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94(5):1713–1722CrossRefPubMed
12.
Zurück zum Zitat Brady MJ, Thomas J, Wong TZ, et al. (2009) Adrenal nodules at FDG PET-CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm 1. Radiology 250(2):523–530CrossRefPubMed Brady MJ, Thomas J, Wong TZ, et al. (2009) Adrenal nodules at FDG PET-CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm 1. Radiology 250(2):523–530CrossRefPubMed
13.
Zurück zum Zitat Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET-CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Am J Roentgenol 192(4):956–962CrossRef Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET-CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Am J Roentgenol 192(4):956–962CrossRef
14.
Zurück zum Zitat Vikram R, Yeung HD, Macapinlac HA, Iyer RB (2008) Utility of PET-CT in differentiating benign from malignant adrenal nodules in patients with cancer. AJR Am J Roentgenol 191(5):1545–1551CrossRefPubMed Vikram R, Yeung HD, Macapinlac HA, Iyer RB (2008) Utility of PET-CT in differentiating benign from malignant adrenal nodules in patients with cancer. AJR Am J Roentgenol 191(5):1545–1551CrossRefPubMed
15.
Zurück zum Zitat Tessonnier L, Sebag F, Palazzo F, et al. (2008) Does 18F-FDG PET-CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35(11):2018–2025CrossRefPubMed Tessonnier L, Sebag F, Palazzo F, et al. (2008) Does 18F-FDG PET-CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35(11):2018–2025CrossRefPubMed
16.
Zurück zum Zitat Sung YM, Lee KS, Kim B-T, et al. (2008) 18F-FDG PET versus 18F-FDG PET-CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients. Korean J Radiol 9(1):19–28CrossRefPubMedPubMedCentral Sung YM, Lee KS, Kim B-T, et al. (2008) 18F-FDG PET versus 18F-FDG PET-CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients. Korean J Radiol 9(1):19–28CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Park BK, Kim CK, Kim B, Choi JY (2007) Comparison of delayed enhanced CT and 18F-FDG PET-CT in the evaluation of adrenal masses in oncology patients. J Comput Assist Tomogr 31(4):550–556CrossRefPubMed Park BK, Kim CK, Kim B, Choi JY (2007) Comparison of delayed enhanced CT and 18F-FDG PET-CT in the evaluation of adrenal masses in oncology patients. J Comput Assist Tomogr 31(4):550–556CrossRefPubMed
18.
Zurück zum Zitat Han SJ, Kim TS, Jeon SW, et al. (2007) Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Pract 61(5):802–809CrossRefPubMed Han SJ, Kim TS, Jeon SW, et al. (2007) Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Pract 61(5):802–809CrossRefPubMed
19.
Zurück zum Zitat Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET-CT in the evaluation of adrenal masses. J Nucl Med. 47(1):32–37PubMed Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET-CT in the evaluation of adrenal masses. J Nucl Med. 47(1):32–37PubMed
20.
Zurück zum Zitat Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD (2006) FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33(1):29–35CrossRefPubMed Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD (2006) FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 33(1):29–35CrossRefPubMed
21.
Zurück zum Zitat Blake MA, Slattery JM, Kalra MK, et al. (2006) Adrenal Lesions: characterization with fused PET-CT image in patients with proved or suspected malignancy—initial experience 1. Radiology 238(3):970–977CrossRefPubMed Blake MA, Slattery JM, Kalra MK, et al. (2006) Adrenal Lesions: characterization with fused PET-CT image in patients with proved or suspected malignancy—initial experience 1. Radiology 238(3):970–977CrossRefPubMed
22.
Zurück zum Zitat Kumar R, Xiu Y, Jian QY, et al. (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45(12):2058–2062PubMed Kumar R, Xiu Y, Jian QY, et al. (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45(12):2058–2062PubMed
23.
Zurück zum Zitat Frilling A, Tecklenborg K, Weber F, et al. (2004) Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136(6):1289–1296CrossRefPubMed Frilling A, Tecklenborg K, Weber F, et al. (2004) Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136(6):1289–1296CrossRefPubMed
24.
Zurück zum Zitat Yun M, Kim W, Alnafisi N, et al. (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42(12):1795–1799PubMed Yun M, Kim W, Alnafisi N, et al. (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42(12):1795–1799PubMed
25.
Zurück zum Zitat Gupta NC, Graeber GM, Tamim WJ, et al. (2001) Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. Clin Lung Cancer 3(1):59–64CrossRefPubMed Gupta NC, Graeber GM, Tamim WJ, et al. (2001) Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. Clin Lung Cancer 3(1):59–64CrossRefPubMed
26.
Zurück zum Zitat Maurea S, Mainolfi C, Bazzicalupo L, et al. (1999) Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173(1):25–29CrossRefPubMed Maurea S, Mainolfi C, Bazzicalupo L, et al. (1999) Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173(1):25–29CrossRefPubMed
27.
Zurück zum Zitat Erasmus J, Patz E Jr, McAdams HP, et al. (1997) Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168(5):1357–1360CrossRefPubMed Erasmus J, Patz E Jr, McAdams HP, et al. (1997) Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168(5):1357–1360CrossRefPubMed
28.
Zurück zum Zitat Boland GW, Goldberg MA, Lee MJ, et al. (1995) Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194(1):131–134CrossRefPubMed Boland GW, Goldberg MA, Lee MJ, et al. (1995) Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194(1):131–134CrossRefPubMed
30.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
31.
Zurück zum Zitat Zhou X-HON, McClish DK (2011) Statistical methods in diagnostic medicine, 2nd edn. Hoboken: WileyCrossRef Zhou X-HON, McClish DK (2011) Statistical methods in diagnostic medicine, 2nd edn. Hoboken: WileyCrossRef
32.
Zurück zum Zitat Newson R (2006) Confidence intervals for rank statistics: Somers’ D and extensions. Stata J 6(3):309 Newson R (2006) Confidence intervals for rank statistics: Somers’ D and extensions. Stata J 6(3):309
33.
Zurück zum Zitat Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11S–20SCrossRefPubMed Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11S–20SCrossRefPubMed
Metadaten
Titel
Diagnostic performance of 18-F-FDG-PET–CT in adrenal lesions using histopathology as reference standard
verfasst von
Emre Altinmakas
Brian P. Hobbs
Hui Ye
Elizabeth G. Grubbs
Nancy D. Perrier
Victor G. Prieto
Jeffrey E. Lee
Chaan S. Ng
Publikationsdatum
24.09.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0915-4

Weitere Artikel der Ausgabe 2/2017

Abdominal Radiology 2/2017 Zur Ausgabe

Classics in Abdominal Imaging

The “butterfly” adrenal gland

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.